Penetrating keratoplasty for keratoconus with or without vernal keratoconjunctivitis

Cornea

Volumn 28, Issue 1, 2009, Pages 14-18

  Wagoner, Michael D ^a,b,c   Ba Abbad, Rola ^a  

^a KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Graft survival; Keratoconus; Penetrating keratoplasty; Vernal keratoconjunctivitis

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLOSPORIN; OLOPATADINE;

ADOLESCENT; ADULT; ARTICLE; CATARACT; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; GLAUCOMA; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KERATITIS; KERATOCONUS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PENETRATING KERATOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SUTURE REMOVAL; TREATMENT OUTCOME; VERNAL CONJUNCTIVITIS; VISUAL ACUITY; WOUND DEHISCENCE; ALLERGIC CONJUNCTIVITIS; COMPARATIVE STUDY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; CONJUNCTIVITIS, ALLERGIC; FEMALE; GRAFT SURVIVAL; HUMANS; KERATOCONUS; KERATOPLASTY, PENETRATING; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 62149117661     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31818225dd     Document Type: Article

References (54)

1. Dorrepal SJ, Cao KY, Slomovic AR. Indications for penetrating keratoplasty in a tertiary care referral centre in Canada, 1996-2004. Can J Ophthalmol. 2007;42:244-250.
2. Kanavi MR, Javadi MA, Sanagoo M. Indications for penetrating keratoplasty in Iran. Cornea. 2007;26:561-563.
3. Fasolo A, Frigo AC, Bvohm E, et al. The CORTES study: corneal transplant indications and graft survival in an Italian cohort of patients. Cornea. 2006;25:507-515.
4. Kang PC, Klintworth GK, Kim T, et al. Trends in the indications for penetrating keratoplasty, 1980-2001. Cornea. 2005;24:801-803.
5. Yahalom C, Mechoulam H, Solomon A, et al. Forty years of changing indications in penetrating keratoplasty in Israel. Cornea. 2005;24: 256-258.
6. Al-Towerki A, Al-Rajhi A, Wagoner MD. Changing indications for keratoplasty at the King Khaled Eye Specialist Hospital (1983-2002). Cornea. 2004;23:584-588.
7. Al-Yousuf N, Mavrikakis I, Mavrikakis E, et al. Penetrating keratoplasty: indications over a 10 year period. Br J Ophthalmol. 2004;88:998-1001.
8. Claesson M, Armitage WJ. Corneal grafts at St John Eye Hospital, Jerusalem, January 2001-November 2002. Br J Ophthalmol. 2004;88: 858-860.
9. Edwards M, Clover GM, Brookes N, et al. Indications for corneal transplantation in New Zealand: 1991-1999. Cornea. 2002;21:152-155.
10. Cosar CB, Sridhar MS, Cohen EJ, et al. Indications for penetrating keratoplasty and associated procedures, 1996-2000. Cornea. 2002;21: 148-151.
11. Dobbins KR, Price FW Jr, Whitson WE. Trends in the indications for penetrating keratoplasty in the midwestern United States. Cornea. 2000; 19:813-816.
12. Pearson AR, Soneji B, Sarvananthan N, et al. Does ethnic origin influence the incidence or severity of keratoconus? Eye. 2000;14:625-628.
13. Cursiefen C, Kuchle M, Naumann GO. Changing indications for penetrating keratoplasty: histopathology of 1,250 corneal buttons. Cornea. 1998;17:468-470.
14. Cameron JA, Al-Rajhi AA, Badr IA. Corneal ectasia in vernal keratoconjunctivitis. Ophthalmology. 1989;96:1615-1623.
15. Pramanik S, Musch DC, Sutphin JE, et al. Extended long-term outcomes of penetrating keratoplasty for keratoconus. Ophthalmology. 2006;113: 1633-1638.
16. Javadi MA, Motlagh BF, Jafarinasab Z, et al. Outcomes of penetrating keratoplasty in keratoconus. Cornea. 2005;24:941-946.
17. Thompson RW Jr, Price MO, Bowers PJ, et al. Long-term graft survival after penetrating keratoplasty. Ophthalmology. 2003;110:1396-1402.
18. Olson RJ, Pingree M, Ridges R, et al. Penetrating keratoplasty: a longterm review of results and complications. J Cataract Refract Surg. 2000; 26:987-991.
19. Inoue K, Amano S, Oshika T, et al. A 10-year review of penetrating keratoplasty. Jpn J Ophthalmol. 2000;44:139-145.
20. Brierly SC, Izquierdo L Jr, Mannis MJ. Penetrating keratoplasty for keratoconus. Cornea. 2000;19:329-332.
21. Lim L, Pesudovs K, Coster DJ. Penetrating keratoplasty for keratoconus: visual outcome and success. Ophthalmology. 2000;107:1125-1131.
22. Buzard KA, Fundingsland BR. Corneal transplant for keratoconus: results in early and late disease. J Cataract Refract Surg. 1997;23:398-406.
23. Koralewska-Makar A, Floren I, Stenevi U. The results of penetrating keratoplasty for keratoconus. Acta Ophthalmol Scand. 1996;74:187-190.
24. Sharif KW, Casey TA. Penetrating keratoplasty for keratoconus: complications and long-term success. Br J Ophthalmol. 1991;75: 142-146.
25. Paglen PG, Fine M, Abbott RL, et al. The prognosis for keratoplasty in keratoconus. Ophthalmology. 1982;89:651-654.
26. Egrilmez S, Sahin S, Yagci A. The effect of vernal keratoconjunctivitis on clinical outcomes of penetrating keratoplasty for keratoconus. Can J Ophthalmol. 2004;39:772-777.
27. Mahmood MA, Wagoner MD. Penetrating keratoplasty in eyes with keratoconus and vernal keratoconjunctivitis. Cornea. 2000;19:468-470.
28. Flynn TH, Ohbayashi M, Ikeda Y, et al. Effect of allergic conjunctival inflammation on the allogeneic response to donor Cornea. Invest Ophthalmol Vis Sci. 2007;48:4044-4049.
29. Bonini S, Sacchetti M, Mantelli F, et al. Clinical grading of vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol. 2007;7:436-441.
30. Kumagai N, Fukuda K, Fujitsu Y, et al. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog Retin Eye Res. 2006;25:165-187.
31. Bonini S, Lambiase A, Sgrulletta R, et al. Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol. 2003;3:381-387.
32. Bonini S, Lambiase A, Schiavone M, et al. Estrogen and progesterone receptors in vernal keratoconjunctivitis. Ophthalmology. 1995;102:1374- 1379.
33. Al Suhaibani AH, Al-Rajhi AA, Al-Motowa S, et al. Inverse relationship between age and severity and sequelae of acute corneal hydrops associated with keratoconus. Br J Ophthalmol. 2007;91:984-985.
34. Ebihara N, Funaki T, Murakami A, et al. Mast cell chymase decreases the barrier function and inhibits the migration of corneal epithelial cells. Curr Eye Res. 2005;30:1061-1069.
35. Dogru M, Okada N, Asano-Kato N, et al. Atopic ocular surface disease: implications on tear function and ocular surface mucins. Cornea. 2005;24: S18-S23.
36. Dogru M, Karakaya H, Ozcetin H, et al. Tear function and ocular surface changes in keratoconus. Ophthalmology. 2003;110:1110-1118.
37. Garg P, Bansal AK, Sangwan VS. Recurrent shield ulcer following penetrating keratoplasty for keratoconus associated with vernal kerato-conjunctivitis. Indian J Ophthalmol. 2003;51:79-80.
38. Tabbara KF. Ocular complications of vernal keratoconjunctivitis. Can J Ophthalmol. 1999;34:88-92.
39. Trocme SD, Gleich GJ, Kephart GM, et al. Eosinophil granule major basic protein inhibition of corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 1994;35:3051-3056.
40. Trocme SD, Kephart GM, Bourne WM, et al. Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis. Am J Ophthalmol. 1993;115:640-643.
41. Gedik S, Akova YA, Gur S. Secondary bacterial keratitis associated with shield ulcer caused by vernal conjunctivitis. Cornea. 2006;25:974-976.
42. Sridhar MS, Gopinathan U, Rao GN. Fungal keratitis associated with vernal keratoconjunctivitis. Cornea. 2003;22:80-81.
43. Arora R, Gupta S, Raina UK, et al. Penicillium keratitis in vernal keratoconjunctivitis. Indian J Ophthalmol. 2002;50:215-216.
44. Ballow M, Donshik PC, Rapacz P, et al. Tear lactoferrin levels in patients with external inflammatory ocular disease. Invest Ophthalmol Vis Sci. 1987;28:543-535.
45. Cameron JA. Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. Ophthalmology. 1995;102:985-993.
46. Kerr N, Stern GA. Bacterial keratitis associated with vernal keratocon-junctivitis. Cornea. 1992;11:355-359.
47. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology. 1994;101:1536-1547.
48. Wagoner MD, Ba-Abbad R, Sutphin JE, et al. Corneal transplant survival after onset of severe endothelial rejection. Ophthalmology. 2007;114: 1630-1636.
49. Al-Mohaimeed M, Al-Shahwan S, Al-Torbak A, et al. Escalation of glaucoma therapy after penetrating keratoplasty. Ophthalmology. 2007; 114:2281-2286.
50. Wagoner MD, Al-Swailem SA, Sutphin JE, et al. Bacterial keratitis after penetrating keratoplasty: incidence, microbiological profile, graft survival, and visual outcome. Ophthalmology. 2007;114:1073-1079.
51. D'Elios M, Del Prete G. Th1/Th2 balance in human disease. Transplant Proc. 1998;30:2373-2377.
52. Leonardi A, Fregona IA, Plebani M, et al. Th1- and Th2-type cytokines in chronic ocular allergy. Graefes Arch Clin Exp Ophthalmol. 2006;244: 1240-1245.
53. Streilein JW. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol. 2003;74:179-185.
54. Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res. 2002;21:319-339.